Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases

INTRODUCTION: The aim of this work is to evaluate baricitinib safety with respect to venous thromboembolism (VTE), major adverse cardiovascular events (MACE), and serious infection relative to tumor necrosis factor inhibitors (TNFi) in patients with rheumatoid arthritis (RA). METHODS: Patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Salinas, Claudia A., Louder, Anthony, Polinski, Jennifer, Zhang, Tancy C., Bower, Hannah, Phillips, Syd, Song, Yufei, Rashidi, Emaan, Bosan, Rafia, Chang, Hsiu-Ching, Foster, Nicole, Gershenson, Bernice, Yamanaka, Hisashi, Kishimoto, Mitsumasa, Tanaka, Yoshiya, Fischer, Peter, Zhu, Baojin, Faries, Douglas, Mai, Xiaodan, Doherty, Brett T., Grelaud, Angela, Thurin, Nicolas H., Askling, Johan, Deberdt, Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660195/
https://www.ncbi.nlm.nih.gov/pubmed/36371760
http://dx.doi.org/10.1007/s40744-022-00505-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660195/
https://www.ncbi.nlm.nih.gov/pubmed/36371760
http://dx.doi.org/10.1007/s40744-022-00505-1

Ejemplares similares